HUMAN-MALIGNANT MESOTHELIAL CELLS - VARIABILITY OF ULTRASTRUCTURAL FEATURES IN ESTABLISHED AND NUDE-MICE TRANSPLANTED CELL-LINES

被引:9
作者
FLEURYFEITH, J
KHEUANG, L
ZENG, L
BIGNON, J
BOUTIN, C
MONNET, I
JAURAND, MC
机构
[1] CHU HENRI MONDOR,DEPT HISTOL,F-94010 CRETEIL,FRANCE
[2] FAC MED CRETEIL,INST MONDOR MED MOLICULAIRE,INSERM,U139,F-94010 CRETEIL,FRANCE
[3] HOP CONCEPTION,F-13385 MARSEILLE,FRANCE
关键词
DIFFERENTIATION; MESOTHELIOMA; MESOTHELIOMA CELL LINES; ULTRASTRUCTURE;
D O I
10.1002/path.1711770215
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to determine, by transmission electron microscopy, the differentiation features of 21 human malignant mesothelioma cell lines (HMCLs) established from 13 specimens of 12 confirmed human malignant mesotheliomas, and of tumours induced in nude mice injected with 16 HMCLs. Fifty per cent of HMCLs showed typical mesothelial differentiation (long and slender microvilli, desmosomes, perinuclear intermediate filaments): 29 per cent did not show differentiation: and the remainder were poorly differentiated. Three human tumour specimens gave several different HMCLs: the cell lines obtained from a given tumour exhibited variable mesothelial differentiation. Eleven HMCLs were compared with the native tumour. Four were similar to the tumour and seven were less well differentiated, in most cases in relation to their microvilli. With six HMCLs, tumours induced in nude mice were less well differentiated than the corresponding cell lines, whereas with four HMCLs, rumours were equally or better differentiated. However, in most nude mice tumours, typical mesothelial microvilli were present. These results show that cell lines established from malignant mesothelioma may exhibit dedifferentiated features. However, while the variability in ultrastructural differentiation may result from the culture microenvironment, it could also be related to the state of differentiation, of the native tumour sample and to tumour cell heterogeneity.
引用
收藏
页码:209 / 215
页数:7
相关论文
共 19 条
[1]  
ALLEY MC, 1988, CANCER RES, V48, P589
[2]  
BEDROSSIAN CWM, 1992, SEMIN DIAGN PATHOL, V9, P124
[3]   IMMUNOCYTOCHEMISTRY OF MALIGNANT MESOTHELIOMA - OV632 AS A MARKER OF MALIGNANT MESOTHELIOMA [J].
DELAHAYE, M ;
HOOGSTEDEN, HC ;
VANDERKWAST, TH .
JOURNAL OF PATHOLOGY, 1991, 165 (02) :137-143
[4]  
DONNA A, 1989, CANCER, V63, P1331, DOI 10.1002/1097-0142(19890401)63:7<1331::AID-CNCR2820630718>3.0.CO
[5]  
2-3
[6]  
FLEURYFEITH J, 1989, BIOL CELL, V65, P45
[7]  
GERWIN BI, 1987, CANCER RES, V47, P6180
[8]   CYTOGENETIC ANALYSIS OF MALIGNANT MESOTHELIOMA [J].
HAGEMEIJER, A ;
VERSNEL, MA ;
VANDRUNEN, E ;
MORET, M ;
BOUTS, MJ ;
VANDERKWAST, TH ;
HOOGSTEDEN, HC .
CANCER GENETICS AND CYTOGENETICS, 1990, 47 (01) :1-28
[9]  
JAURAND MC, 1993, EUR RESPIR J, V6, P319
[10]  
KLOMINEK J, 1989, CANCER RES, V49, P6118